{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:31:32Z","timestamp":1778308292487,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T00:00:00Z","timestamp":1446768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1245\/s10434-015-4960-y","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T20:20:23Z","timestamp":1446841223000},"page":"1501-1507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results"],"prefix":"10.1245","volume":"23","author":[{"given":"Paul","family":"Sugarbaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwuemeka","family":"Ihemelandu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Bijelic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,6]]},"reference":[{"key":"4960_CR1","unstructured":"US FDA. Quantitative assessment of the prevalence of unsuspected uterine sarcoma in women undergoing treatment of uterine fibroids: summary and key findings. Silver Spring: US FDA. 2014. http:\/\/www.fda.gov\/downloads\/MedicalDevices\/Safety\/AlertsandNotices\/UCM393589.pdf . Accessed 5 Dec 2014."},{"key":"4960_CR2","first-page":"1","volume-title":"Cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas","author":"PH Sugarbaker","year":"2012","unstructured":"Sugarbaker PH. An overview of peritonectomy, visceral resections, and perioperative chemotherapy for peritoneal surface malignancy. In: Sugarbaker PH editor. Cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas. Woodbury: Cine-Med Publishing; 2012. p. 1\u201330."},{"key":"4960_CR3","first-page":"185092","volume":"2011","author":"K Speeten Van der","year":"2011","unstructured":"Van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH. Pharmacokinetic study of perioperative intravenous ifosfamide. Int J Surg Oncol. 2011;2011:185092.","journal-title":"Int J Surg Oncol."},{"key":"4960_CR4","first-page":"49","volume":"15","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Current methodologies for clinical assessment of patients with peritoneal carcinomatosis. J Exp Clin Cancer Res. 1996;15:49\u201358.","journal-title":"J Exp Clin Cancer Res."},{"key":"4960_CR5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1245\/ASO.2006.03.079","volume":"13","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH, Alderman R, Edwards G, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol. 2006;13:635\u201344.","journal-title":"Ann Surg Oncol."},{"key":"4960_CR6","first-page":"1","volume-title":"Doxorubicin: biosynthesis, clinical uses and health implications","author":"PH Sugarbaker","year":"2014","unstructured":"Sugarbaker PH. Intraperitoneal doxorubicin: rationale, pharmacokinetic studies, and clinical results. In: Pache M editor. Doxorubicin: biosynthesis, clinical uses and health implications. New York: Nova Science Publishers; 2014. p. 1\u201320."},{"key":"4960_CR7","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1245\/s10434-007-9463-z","volume":"14","author":"SJ Lim","year":"2007","unstructured":"Lim SJ, Cormier JN, Feig BW, et al. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol. 2007;14:2309\u201318.","journal-title":"Ann Surg Oncol."},{"key":"4960_CR8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cncr.10176","volume":"94","author":"CR Rossi","year":"2002","unstructured":"Rossi CR, Foletto M, Mocellin S, et al. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis. Phase 1 study. Cancer. 2002;94:492\u20139.","journal-title":"Cancer."},{"key":"4960_CR9","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/cncr.20192","volume":"100","author":"CR Rossi","year":"2004","unstructured":"Rossi CR, Deraco M, De Simone M, et al. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomas. Clinical outcome and prognostic factors in 60 consecutive patients. Cancer. 2004;100:1943\u201350.","journal-title":"Cancer."},{"key":"4960_CR10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10434-999-0645-8","volume":"6","author":"FC Eilber","year":"1999","unstructured":"Eilber FC, Rosen G, Forscher C, Nelson SD, Dorey FJ, Eilber FR. Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas. Ann Surg Oncol. 1999;6:645\u201350.","journal-title":"Ann Surg Oncol."},{"key":"4960_CR11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ejso.2005.04.010","volume":"31","author":"S Bonvalot","year":"2005","unstructured":"Bonvalot S, Cavalcanti A, Le Pechoux C, et al. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol. 2005;31:917\u201323.","journal-title":"Eur J Surg Oncol."},{"key":"4960_CR12","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1245\/s10434-010-1178-x","volume":"17","author":"D Baratti","year":"2010","unstructured":"Baratti D, Pennacchioli E, Kusamura S, et al. Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Ann Surg Oncol. 2010;17:3220\u20138.","journal-title":"Ann Surg Oncol."},{"key":"4960_CR13","unstructured":"Sugarbaker PH. Sarcomatosis and imitanib-resistant gistosis: diagnosis and therapeutic options. In: Sugarbaker PH editor. Cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas. Woodbury: Cine-Med Publishing; 2012. P. 127\u201336."},{"key":"4960_CR14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1245\/s10434-010-1229-3","volume":"18","author":"G Munene","year":"2011","unstructured":"Munene G, Mack LA, Temple WJ. Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy. Ann Surg Oncol. 2011;18:207\u201313.","journal-title":"Ann Surg Oncol."},{"key":"4960_CR15","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1245\/s10434-012-2240-7","volume":"19","author":"GI Salti","year":"2012","unstructured":"Salti GI, Ailabouni L, Undevia S. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis. Ann Surg Oncol. 2012;19:1410\u20135.","journal-title":"Ann Surg Oncol."},{"key":"4960_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2008.03.010","volume":"109","author":"ML Hensley","year":"2008","unstructured":"Hensley ML, Blessing JA, Mannel R, et al. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol. 2008;109:329\u201334.","journal-title":"Gynecol Oncol."},{"key":"4960_CR17","first-page":"183","volume-title":"Cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy Textbook and video atlas","author":"PH Sugarbaker","year":"2012","unstructured":"Sugarbaker PH, van der Speeten K, Stuart OA, Chang D, Mahteme H. Patient- and treatment-related variables, adverse events and their statistical relationship for treatment of peritoneal metastases. In: Sugarbaker PH editor. Cytoreductive surgery and perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas. Woodbury: Cine-Med Publishing; 2012. p. 183\u2013206."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4960-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-015-4960-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4960-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T11:22:13Z","timestamp":1559647333000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-015-4960-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,6]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["4960"],"URL":"https:\/\/doi.org\/10.1245\/s10434-015-4960-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,6]]}}}